Antibiotic susceptibility patterns of bacterial isolates of patients with upper respiratory tract infections

Autores

  • Kalim Ullah Faculty of Pharmacy & Health Sciences, University of Balochistan, Quetta, Pakistan
  • Marvi Baloch Faculty of Pharmacy & Health Sciences, University of Balochistan, Quetta, Pakistan
  • Fahad Saleem Faculty of Pharmacy & Health Sciences, University of Balochistan, Quetta, Pakistan https://orcid.org/0000-0001-8100-8992
  • Ayaz Ali Khan Faculty of Pharmacy & Health Sciences, University of Balochistan, Quetta, Pakistan
  • Hamid Saeed University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan https://orcid.org/0000-0002-1400-4825
  • Muhammad Islam University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan

DOI:

https://doi.org/10.1590/s2175-97902022e20484

Palavras-chave:

Ceftazidime, P, aeruginosa, Amikacin, URTIs, Pakistan, Antibiotic Resistance

Resumo

To evaluate the antibiotic susceptibility patterns in URTIs reporting to tertiary hospitals of Lahore. A cross-sectional study employing 259 culture sensitivity reports obtained from tertiary care hospitals of Lahore. Using SPSS, descriptive statistics were used to estimate frequencies and percentages. In URTIs, S. aureus (5%) was the frequent gram-positive isolate followed by MRSA (1.5%) and MSSA (1.5%), while P. aeruginosa (15.8%) was the prevalent gram-negative isolate followed by Klebsiella (13.1%) and E. coli (6.9%). Against P. aeruginosa, ceftazidime (7.7%), cefuroxime/ceftriaxone (4.6%), amoxicillin (4.3%) and ciprofloxacin (4.2%), were tested resistant, while imipenem (11.2%), ciprofloxacin (9.2%), amikacin (9.2%), meropenem/ levofloxacin/gentamicin (8.1%) and piptaz (6.9%) were found sensitive. Against Klebsiella, carbepenems (7.3%), amikacin (6.5%), ciprofloxacin (5.4%) and gentamicin (5%) were tested sensitive, whereas, ceftazidime (8.5%), ceftriaxone (5.8%), cefaclor (5.5%), ampicillin (4.6%), co-amoxiclave (4.2%) and ciftazidime/ciprofloxacin (3.8%) were found resistant. Overall, imipenem (35%), meropenem (30.8%) and amikacin (31.9%) were the three most sensitive antibiotics, while ceftazidime (25.4%), ceftriaxone (19.2%) and ampicillin (18.5%) were the three most resistant antibiotics. Data suggested that P.aeruginosa and Klebsiella, were the most frequent bacterial isolates in URTIs of Lahore. These isolates were resistant to ampicillin, cefuroxime and ceftazidime, but were sensitive to carbapenem and aminoglycosides.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Ahmed SMA-Z, Abdelrahman SS, Saad DM, Osman IS, Osman MG, Khalil EAG. Etiological trends and patterns of antimicrobial resistance in respiratory infections. Open Microbiol J. 2018;12:34-40.

Akter S, Shamsuzzaman S, Jahan F. Community acquired bacterial pneumonia: aetiology, laboratory detection and antibiotic susceptibility pattern. Malays J Pathol. 2014;36(2):97-103.

Ali I, Butt M. Antibiotic susceptibility pattern of bacterial isolates from patients of respiratory tract infection at 43 centers in Punjab, Pakistan. Clin Exp Pharmacol. 2017;7:229. doi:10.4172/2161-1459.1000229

» https://doi.org/10.4172/2161-1459.1000229

Aljanaby AAJ, Aljanaby IAJ. Profile of Antimicrobial Resistance of Aerobic Pathogenic Bacteria isolated from Different Clinical Infections in Al-Kufa Central Hospital- Iraq During period from 2015 to 2017. Res J Pharm Technol. 2017;10(10):3264-3270.

Alshami AK, Mohamed Ibrahim MI, Abdorabbo A. Evaluation of the quality of prescriptions with antibiotics in the government hospitals of Yemen. J Clin Diagn Res. 2011;5(4):808-812.

Amarasinghe N, Athavan M, Jayamanne D, Rajapakshe Y, Sadikeen A, Gunasekara K, et al. Bacterial profile and antibiotic susceptibility pattern of adult lower respiratory tract infections in Colombo, Sri Lanka. J Health Soc Sci. 2018;3(1):27-36.

Avorn J, Harvey K, Soumerai SB, Herxheimer A, Plumridge R, Bardelay G. Information and education as determinants of antibiotic use: report of Task Force 5. Rev Infect Dis. 1987;9:S286-S296.

Butt SZ, Ahmad M, Saeed H, Saleem Z, Javaid Z. Post- surgical antibiotic prophylaxis: Impact of pharmacist’s educational intervention on appropriate use of antibiotics. J Infect Public Health. 2019;12(6):854-860.

Carroll K, Larry R. Microbiology and Laboratory Diagnosis of Upper Respiratory Tract Infections. Clin Infect Dis. 1996;23(3):442-448.

Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis. 1997;175(6):1440-1445.

Falagas ME, Mourtzoukou EG and Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101(9):1845-1863.

Fendrick AM, Saint S, Brook I, Jacobs MR, Pelton S, Sethi S. Diagnosis and treatment of upper respiratory tract infections in the primary care setting. Clin Ther. 2001;23(10):1683-1706.

Fleming DW, Cochi SL, Hightower AW, Broome CV. Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics. 1987;79(1):55-60.

Harris AM, Hicks LA and Qaseem A. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016;164(6):425-434.

Hedrick JA. Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins. Expert Rev Anti Infect Ther. 2010;8(1):15-21.

Heikkinen T, Marttila J, Salmi AA, Ruuskanen O. Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses. J Clin Microbiol. 2002;40(11):4337-4339.

Jain N, Lodha R and Kabra S. Upper respiratory tract infections. Indian J Pediatr. 2001;68(12):1135-1138.

Khudhair ME, Hameed IH, Mekhlef AK. A Prospective and Retrospective Study of Acute Bronchitis in Hillah City-Iraq. Res J Pharm Technol . 2017:10(11):3839-3844.

Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):3463-3470.

Lawrence R, Jeyakumar E. Antimicrobial resistance: a cause for global concern. BMC Proc. 2013;7(suppl3):S1.

Leekha S, Terrell CL and Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011;86(2):156-167.

Lönnroth K, Migliori GB, Abubakar I, D`Ambrosio L, de Vries G, Diel R, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015;45(4):928-952.

Mahdi FA, Saadoon AS and Haider HS. Prevalence and Antibacterial Resistance of Gram Negative Bacteria Causing Respiratory Tract Infection In Critically Ill Patients. J Fac Med Baghdad. 2014;56(3):273-277.

Manikandan C, Amsath A. Antibiotic susceptibility of bacterial strains isolated from patients with respiratory tract infections. Int J Pure Appl Zool. 2013;1(1):61-69.

Mastro TD, Ghafoor A, Nomani NK, Ishaq Z, Anwar F, Granoff DM, et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet. 1991;337(8734):156-159.

MMIDSP. (2019) MMIDSP’s antimicrobial guidelines Available at: https://www.mmidsp.com/guidelines/

» https://www.mmidsp.com/guidelines/

Mourtzoukou E, Falagas ME. Exposure to cold and respiratory tract infections. Inter J Tuber Lung Dis. 2007;11(9):938-943.

Pallasch TJ. Antibiotic resistance. Dent Clin North Am. 2003;47(4):623-639.

Prestinaci F, Pezzotti P and Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-318.

Reimer LG, Carroll KC. Role of the Microbiology Laboratory in the Diagnosis of Lower Respiratory Tract Infections. Clin Infect Dis . 1998;26(3):742-748.

Rezal RS, Hassali MA, Alrasheedy AA, Saleem F, Yusof FAM, Kamal M, et al. Prescribing patterns for upper respiratory tract infections: a prescription-review of primary care practice in Kedah, Malaysia, and the implications. Expert Rev Anti Infect Ther . 2015;13(12):1547-1556.

Rodloff A, Bauer T, Ewig S, Kujath P, Muller E. Susceptible, intermediate, and resistant - the intensity of antibiotic action. Dtsch Arztebl Int. 2008;105(39):657-662.

Sabir R, Alvi SFD, Fawwad A. Antimicrobial susceptibility pattern of aerobic microbial isolates in a clinical laboratory in Karachi-Pakistan. Pak J Med Sci. 2013;29(3):851-855.

Saleem Z, Saeed H, Ahmad M, Yousaf M, Hassan HB, Javed A, et al. Antibiotic self-prescribing trends, experiences and attitudes in upper respiratory tract infection among pharmacy and non-pharmacy students: A study from Lahore. PLoS One. 2016;11:e0149929. doi: 10.1371/journal.pone.0149929

» https://doi.org/10.1371/journal.pone.0149929

Saleem Z, Saeed H, Hassali MA, Godman B, Asif U, Yousaf M, et al. Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: a longitudinal surveillance and implications. Antimicrob Resist Infect Control. 2019;8:188.

Samad A, Ahmed T, Rahim A, Khalil A, Ali I. Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas aeruginosa isolated from patients of respiratory tract infections in a Tertiary Care Hospital, Peshawar. Pak J Med Sci . 2017;33(3):670-674.

Sarwar MR, Saqib A, Iftikhar S, Sadiq T. Antimicrobial use by WHO methodology at primary health care centers: a cross sectional study in Punjab, Pakistan. BMC Infect Dis. 2018;18(1):492.

Siddalingappa C, Kalpana L, Sagar Puli VT, Vasudha TK, Acharya A. Sensitivity pattern of bacteria causing respiratory tract infections in a tertiary care centre. Int J Basic Clin Pharmacol. 2013;2:590-595.

Sulis G, Adam P, Nafade V, Gore G, Daniels B, Daftary A, et al. Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis. PLoS Med. 2020;17(6): e1003139.

Vázquez R, García E, García P. Phage lysins for fighting bacterial respiratory infections: a new generation of antimicrobials. Front Immunol. 2018;9:2252.

Zoorob R, Sidani MA, Fremont RD, Kihlberg C. Antibiotic use in acute upper respiratory tract infections. Am Fam Physician. 2012;86(9):817-822.

Downloads

Publicado

2022-12-23

Edição

Seção

Original Article

Como Citar

Antibiotic susceptibility patterns of bacterial isolates of patients with upper respiratory tract infections. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e20484